South Wales, Sept. 11 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Anageria" on Sept. 1. The details about the trademark application no. UK00004438749 published in the journal no. 2026/037 (Sept. 11).
barry sharples filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical and medicinal preparations and substances; biological preparations for medical purposes; biopharmaceutical preparations; biological therapeutic preparations; pharmaceutical preparations for the treatment and prevention of diseases and disorders associated with ageing; pharmaceutical preparations for promoting healthy ageing and longevity; therapeutic preparations derived from stem cells; stem cell-derived therapeutic preparations; cell-derived biological preparations for medical purposes; cell-free biological preparations for medical purposes; preparations containing or comprising stem cell secretome; stem cell secretome for medical purposes; conditioned media derived from stem cells for medical purposes; extracellular vesicles for medical purposes; exosomes for medical purposes; pharmaceutical preparations containing extracellular vesicles or exosomes; regenerative medicine preparations; preparations for use in regenerative medicine; preparations for tissue repair and regeneration; diagnostic preparations for medical purposes; nutritional supplements; dietary supplements; nutraceutical preparations; dietetic substances adapted for medical use.
Class 42 : Scientific and technological services; scientific research; biological research; biotechnology research; pharmaceutical research and development; research and development in the field of biotechnology; research and development in the field of pharmaceuticals; research and development in the field of regenerative medicine; research and development relating to stem cells and stem cell-derived products; research and development relating to stem cell secretome; research and development relating to extracellular vesicles and exosomes; research relating to cellular ageing, biological ageing and longevity; research and development in the field of human longevity and healthy ageing; drug discovery services; pharmaceutical drug development services; development of pharmaceutical and biological preparations; development of therapeutic preparations derived from stem cells; laboratory research services; laboratory testing services; biological analysis; biochemical research and analysis; cell biology research; molecular biology research; genetic research; genomic research; proteomic research; research relating to extracellular vesicles; scientific analysis; pre-clinical research services; clinical research; clinical trial services; provision of scientific information relating to biotechnology, pharmaceuticals, stem cell research, regenerative medicine, ageing and longevity; consultancy relating to biotechnology, pharmaceutical research and scientific research.
Class 44 : Medical services; healthcare services; medical consultancy services; medical advisory services; medical testing services; medical diagnostic services; medical analysis services; health assessment services; medical screening services; medical services relating to healthy ageing and longevity; medical services relating to regenerative medicine; provision of medical information relating to ageing, longevity and healthy ageing; consultancy relating to health, ageing and longevity; provision of medical information relating to therapeutic preparations; medical laboratory services for diagnostic purposes; genetic testing services for medical purposes; genetic analysis services for medical purposes; cell-based and biomarker-based medical diagnostic services; providing health and medical information.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004438749
Disclaimer: Curated by HT Syndication.
